How Personalized Care Leads to Faster Recovery Times
January 17, 2023
Understanding the social determinants of health and taking a more personalized approach to understand an injured employees’ life circumstances can help them recover faster.
The Long, Winding Road of Drug Pricing
April 10, 2022
One of the most persistent and complex challenges facing workers’ compensation claims administrators and insurers is managing prescription drug costs. The problems around prescription drugs are pervasive throughout the health care industry, have been around for over a century, and cover a wide range of issues including accessibility, efficacy and cost. For workers’ compensation payors, cost has been the most challenging issue.
Top Auto Casualty Trends to Watch in 2022
January 27, 2022
9 MIN READThe year 2021 brought new challenges to the auto insurance industry—from frequent shifts in miles driven to significant staffing shortages.
Workers’ Compensation: 2022 Trends & Predictions
January 27, 2022
14 MIN READAs we enter 2022 still mired in the COVID-19 pandemic, the workers’ compensation industry faces another challenging year, with payers continuing to cope with staffing shortages, evolving regulatory
P&C Industry Claims Severity: Trends, Drivers and Mitigators
January 25, 2022
3 MIN READClaim severity has always been top of mind for the P&C industry.
Is the Supply Chain Creating Critical Drug Shortages?
December 29, 2021
1 MIN READWith the country well into the holiday season, issues with supply chains have made their way into pharmacies across the nation. Recently, the Food and Drug Administration (FDA) showed that there are about 111 drugs on backorder. These include medications for heart conditions, antibiotics, and cancer drugs. Currently, there are no medications on the list that represent a large volume of active prescriptions for workers’ compensation.
Release of Generic Medications for Workers' Comp in 2022
November 15, 2021
1 MIN READNext year twenty-eight drugs relevant to workers’ compensation are expected to become available as generics. These formulations will be made available once the original drug manufacturer’s brand name period of exclusivity has expired.